Ramadas, MPaul, WDileep, KJAnitha, YSharma, CP2017-03-102017-03-10200017 ,4;405-411https://dspace.sctimst.ac.in/handle/123456789/10002An oral formulation based on liposome encapsulated alginate-chitosan gel capsules was developed for insulin delivery for the treatment of diabetes. Liposome encapsulation helped to increase the encapsulation efficiency of insulin in alginate-chitosan capsules. This formulation delivers insulin in the neutral environment of the intestine, by-passing the acidic media in the stomach, with increased drug absorption and bioavailability. Oral administration of this formulation was found to reduce blood glucose levels when tested in diabetic rats.Chemistry; Engineering; Pharmacology & PharmacyLipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats